The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insomnia Treatment Drugs Market Research Report 2024
Synopsis
Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
The global Insomnia Treatment Drugs market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Treatment Drugs.
Report Scope
The Insomnia Treatment Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Segment by Type
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Segment by Application
Hospital
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
The global Insomnia Treatment Drugs market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Treatment Drugs.
Report Scope
The Insomnia Treatment Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Segment by Type
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Segment by Application
Hospital
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Treatment Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prescription Sleep Aids
1.2.3 Over the Counter (OTC) Sleep Aids
1.3 Market by Application
1.3.1 Global Insomnia Treatment Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Treatment Drugs Market Perspective (2019-2030)
2.2 Insomnia Treatment Drugs Growth Trends by Region
2.2.1 Global Insomnia Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Insomnia Treatment Drugs Historic Market Size by Region (2019-2024)
2.2.3 Insomnia Treatment Drugs Forecasted Market Size by Region (2025-2030)
2.3 Insomnia Treatment Drugs Market Dynamics
2.3.1 Insomnia Treatment Drugs Industry Trends
2.3.2 Insomnia Treatment Drugs Market Drivers
2.3.3 Insomnia Treatment Drugs Market Challenges
2.3.4 Insomnia Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Treatment Drugs Players by Revenue
3.1.1 Global Top Insomnia Treatment Drugs Players by Revenue (2019-2024)
3.1.2 Global Insomnia Treatment Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Insomnia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Treatment Drugs Revenue
3.4 Global Insomnia Treatment Drugs Market Concentration Ratio
3.4.1 Global Insomnia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Treatment Drugs Revenue in 2023
3.5 Insomnia Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Treatment Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Treatment Drugs Breakdown Data by Type
4.1 Global Insomnia Treatment Drugs Historic Market Size by Type (2019-2024)
4.2 Global Insomnia Treatment Drugs Forecasted Market Size by Type (2025-2030)
5 Insomnia Treatment Drugs Breakdown Data by Application
5.1 Global Insomnia Treatment Drugs Historic Market Size by Application (2019-2024)
5.2 Global Insomnia Treatment Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Insomnia Treatment Drugs Market Size (2019-2030)
6.2 North America Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Insomnia Treatment Drugs Market Size by Country (2019-2024)
6.4 North America Insomnia Treatment Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Treatment Drugs Market Size (2019-2030)
7.2 Europe Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Insomnia Treatment Drugs Market Size by Country (2019-2024)
7.4 Europe Insomnia Treatment Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Treatment Drugs Market Size (2019-2030)
8.2 Asia-Pacific Insomnia Treatment Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Treatment Drugs Market Size (2019-2030)
9.2 Latin America Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Insomnia Treatment Drugs Market Size by Country (2019-2024)
9.4 Latin America Insomnia Treatment Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Treatment Drugs Market Size (2019-2030)
10.2 Middle East & Africa Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F.Hoffman La-Roche AG
11.1.1 F.Hoffman La-Roche AG Company Detail
11.1.2 F.Hoffman La-Roche AG Business Overview
11.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Introduction
11.1.4 F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.1.5 F.Hoffman La-Roche AG Recent Development
11.2 Merck & Co. Inc.
11.2.1 Merck & Co. Inc. Company Detail
11.2.2 Merck & Co. Inc. Business Overview
11.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Introduction
11.2.4 Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.2.5 Merck & Co. Inc. Recent Development
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Detail
11.3.2 Mylan N.V. Business Overview
11.3.3 Mylan N.V. Insomnia Treatment Drugs Introduction
11.3.4 Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.3.5 Mylan N.V. Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Detail
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Insomnia Treatment Drugs Introduction
11.4.4 Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.4.5 Pfizer, Inc. Recent Development
11.5 Pernix Therapeutics
11.5.1 Pernix Therapeutics Company Detail
11.5.2 Pernix Therapeutics Business Overview
11.5.3 Pernix Therapeutics Insomnia Treatment Drugs Introduction
11.5.4 Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.5.5 Pernix Therapeutics Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Detail
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Insomnia Treatment Drugs Introduction
11.6.4 Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.6.5 Sanofi S.A. Recent Development
11.7 Takeda Pharmaceutical Company Ltd.
11.7.1 Takeda Pharmaceutical Company Ltd. Company Detail
11.7.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Introduction
11.7.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.7.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.8 Sumitomo Dainippon Pharma Co., Ltd
11.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Introduction
11.8.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.10 Vanda Pharmaceuticals, Inc.
11.10.1 Vanda Pharmaceuticals, Inc. Company Detail
11.10.2 Vanda Pharmaceuticals, Inc. Business Overview
11.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Introduction
11.10.4 Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.10.5 Vanda Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
